Source comparison
BPC-157 vs TB-500: Key Differences for Researchers
Compound type Synthetic pentadecapeptide (15 AA) Synthetic analogue of Thymosin Beta-4 (43 AA fragment) Origin Derived from human gastric juice protein Derived from naturally occurring Thymosin Beta-4 Primary mechanism VEGFR2/angiogenesis, NO/cGMP, FAK-paxilli
This comparison does not assign a generated winner or score.
- Compound type
- Synthetic pentadecapeptide (15 AA)
- Synthetic analogue of Thymosin Beta-4 (43 AA fragment)
- Origin
- Derived from human gastric juice protein
- Derived from naturally occurring Thymosin Beta-4
- Primary mechanism
- VEGFR2/angiogenesis, NO/cGMP, FAK-paxillin
- Actin polymerisation, cell migration (G-actin sequestration)
- Key research areas
- Tendon/ligament, gut protection, neurological, wound healing
- Muscle repair, cardiac tissue, wound healing, inflammation
- Endogenous equivalent
- None (no direct endogenous counterpart)
- Yes — Thymosin Beta-4 is naturally produced
- For a full comparison: BPC-157 vs TB-500: Which Peptide Is Better for Healing? or see the sister pillar TB-500 UK: Mechanism, Actin Biology & Research Guide 2026.